ACE2 and infection: Although no genetically resistant ACE2 mutant receptors against SARS-CoV-2 have been recognized in different populations, a wide spectrum in symptoms, disease severity and CFR has been described in different countries, and ACE2 gene has been considered the “first genetic gateway” involved in infection, severity and outcome [109].